Nanoparticle Analyzer (NPA)
Spectradyne LLC, California, United States
The Spectradyne NPA’s innovative combination of nanofluidic circuitry and high sensitivity electronics enables measurements of sub-micron particles that are faster and more precise than competing technologies. Key metrology applications are in protein aggregation for drug development, virus counting, and quality control of additives in nanomaterial-based consumer products.
Primary Application Area: Biotech & Biological Sciences
Technology Development Status: Prototype
Technology Readiness Level: TRL 4
FIGURES OF MERIT
Value Proposition: The Spectradyne NPA is more precise than DLS, faster than TEM, and can measure smaller particles than conventional Coulter counters. Additionally, the NPA is capable of measurements of absolute concentration. The gains in speed and precision will save time and money in the drug formulation and vaccine production industries.
Organization Type: Early-stage Startup (Seed)
Showcase Booth #: 748
GOVT/EXTERNAL FUNDING SOURCES
Government Funding/Support to Date: We have applied for NIH and NSF Phase I SBIR grants.
Primary Sources of Funding: Personal Savings
Looking for: Both Funding and Development Partners